- Release Date: 28/11/22 09:25
- Summary: FDA Approves Early Feasibility Study for DurAVR THV System
- Price Sensitive: Yes
- Download Document 171.92KB
- Forums
- ASX - By Stock
- AVR
- Ann: FDA Approves Early Feasibility Study for DurAVR THV System
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.25 |
Change
-0.040(0.19%) |
Mkt cap ! $407.2M |
Open | High | Low | Value | Volume |
$21.50 | $21.50 | $21.00 | $123.5K | 5.829K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $21.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.48 | 21 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 21.100 |
1 | 949 | 21.000 |
1 | 22 | 20.810 |
1 | 500 | 20.800 |
1 | 22 | 20.760 |
Price($) | Vol. | No. |
---|---|---|
21.480 | 21 | 1 |
21.490 | 338 | 1 |
21.500 | 246 | 1 |
21.600 | 300 | 1 |
21.700 | 421 | 1 |
Last trade - 14.25pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.21 |
  |
Change
-0.040 ( 0.09 %) |
|||
Open | High | Low | Volume | ||
$21.19 | $21.21 | $21.19 | 143 | ||
Last updated 14.24pm 06/05/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online